Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about P38: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
P38 is a protein involved in neurodegeneration research. Key relationships include: activates, regulates, interacts with. Associated with ALS, Aging, Als. Connected to 1019 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | P38 |
| Chromosome | MAPK14: 6p21.31, MAPK11: 22q13.13, MAPK12: 15q21.2, MAPK13: 6p21.31 |
| Protein Type | Kinase |
| Function | Upstream stress signals: Pro-inflammatory cytokines (IL-1β, TNF-α), oxidative stress, UV radiation, heat shock, and ischemia trigger activation |
| Primary Expression | neurons, microglia, and astrocytes |
| Molecular Weight | ~38-40 kDa per isoform |
| Pathways | Akt, Apoptosis, Autophagy, Differentiation, Glycolysis |
| GeneCards | P38 |
| Human Protein Atlas | P38 |
| Associated Diseases | Als, Alzheimer, Alzheimer's disease, Cancer, Carcinoma |
| Known Drugs/Compounds | Benzimidazole-aminopyrimidine hybrids, Gold nanoparticle, N-ACETYLCYSTEINE, p38α MAPK inhibitor, Paeoniflorin, RAPAMYCIN |
| Interactions | ACOX1, ACSL4, AGING, AHR, AIM2, AKT |
| KG Connections | 1682 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
P38["P38"] -->|"phosphorylates"| FOXN3["FOXN3"]
P38["P38"] -->|"regulates"| NF_KB["NF-KB"]
P38["P38"] -->|"associated"| INFLAMMATION["INFLAMMATION"]
P38["P38"] -->|"interacts"| Cancer["Cancer"]
P38["P38"] -->|"interacts"| Fibrosis["Fibrosis"]
P38["P38"] -->|"interacts"| Als["Als"]
GABARAP["GABARAP"] -->|"interacts"| P38["P38"]
HSPA1A["HSPA1A"] -->|"regulates"| P38["P38"]
ATG5["ATG5"] -->|"activates"| P38["P38"]
GABARAP_1["GABARAP"] -->|"activates"| P38["P38"]
style P38 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | inhibits | disease | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| JUN | activates | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Mapk | therapeutic_target | pathway | 1.00 |
| Mapk | inhibits | pathway | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Mapk | activates | pathway | 1.00 |
| Cancer | activates | disease | 1.00 |
| Infection | activates | disease | 1.00 |
| P38 Mapk | activates | pathway | 1.00 |
| CANCER | activates | gene | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| AKT | activates | gene | 1.00 |
| FOXN3 | phosphorylates | gene | 0.95 |
| Inflammation | regulates | disease | 0.95 |
| Tumor | inhibits | disease | 0.95 |
| Cancer | therapeutic_target | disease | 0.95 |
| Inflammation | therapeutic_target | disease | 0.95 |
| FOXN3 | phosphorylates | protein | 0.94 |
| NF-KB | regulates | gene | 0.90 |
| MAPK | upstream_of | pathway | 0.90 |
| p38α MAPK inhibitor | inhibits | compound | 0.90 |
| p38α | part_of | protein | 0.90 |
| Oxidative Stress | inhibits | pathway | 0.90 |
| Nf-Κb | inhibits | pathway | 0.90 |
| TNF-Α | activates | gene | 0.90 |
| Nf-Κb | activates | pathway | 0.90 |
| Neurodegeneration | regulates | disease | 0.85 |
| ATF2 | activates | protein | 0.85 |
| Tumor | regulates | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Tumor | therapeutic_target | disease | 0.85 |
| INFLAMMATION | associated_with | gene | 0.85 |
| Neuroinflammation | activates | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| TDP-43 | associated_with | protein | 0.80 |
| Benzimidazole-aminopyrimidine hybrids | binds | compound | 0.80 |
| TNF-α | regulates | protein | 0.80 |
| Alzheimer's disease | associated_with | disease | 0.80 |
| IL-1β | regulates | protein | 0.80 |
| Benzimidazole-aminopyrimidine hybrids | inhibits | compound | 0.80 |
| LC3 | activates | gene | 0.80 |
| Nf-Κb | therapeutic_target | pathway | 0.80 |
| TNF-Α | inhibits | gene | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | activates | gene | 1.00 |
| ERK | activates | gene | 1.00 |
| JNK | activates | gene | 1.00 |
| PI3K | activates | gene | 1.00 |
| ERK | inhibits | gene | 1.00 |
| ERK1 | activates | gene | 1.00 |
| CYTOKINES | inhibits | gene | 1.00 |
| NF-ΚB | inhibits | gene | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| PRMTM1 | regulates | gene | 0.90 |
| JNK | inhibits | gene | 0.90 |
| NF-ΚB | activates | gene | 0.90 |
| APOPTOSIS | inhibits | gene | 0.90 |
| ROS | activates | gene | 0.90 |
| Paeoniflorin | targets | compound | 0.88 |
| Paeoniflorin | targets | compound | 0.85 |
| DUSP8 | associated_with | gene | 0.80 |
| NEUROTOXICITY | activates | gene | 0.80 |
| ERK1 | regulates | gene | 0.80 |
| AUTOPHAGY | activates | gene | 0.80 |
| NF-ΚB | therapeutic_target | gene | 0.80 |
| TNF | inhibits | gene | 0.80 |
| NEURODEGENERATION | regulates | gene | 0.80 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.80 |
| PI3K | therapeutic_target | gene | 0.80 |
| TNF | activates | gene | 0.80 |
| IL-6 | activates | gene | 0.80 |
| BECN1 | activates | gene | 0.80 |
| Baicalin | interacts_with | compound | 0.75 |
| JNK | regulates | gene | 0.70 |
| BAX | expressed_in | gene | 0.70 |
| ROS | inhibits | gene | 0.70 |
| P53 | inhibits | gene | 0.70 |
| IL-6 | inhibits | gene | 0.70 |
| NADPH | inhibits | drug | 0.70 |
| OXIDATIVE STRESS | inhibits | gene | 0.70 |
| NEURODEGENERATION | activates | gene | 0.70 |
| Parkin | activates | protein | 0.70 |
| Parkin | interacts_with | protein | 0.70 |
| SLC7A11 | activates | gene | 0.70 |
| NEURODEGENERATION | associated_with | gene | 0.70 |
| ERK | regulates | gene | 0.70 |
| ERK1 | associated_with | gene | 0.70 |
| SOD1 | causes | gene | 0.70 |
| TAU | activates | gene | 0.70 |
| SOD1 | phosphorylates | gene | 0.70 |
| TNF | expressed_in | gene | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| STAT3 | activates | gene | 0.70 |
| C-JUN | activates | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| p38α Inhibitor and PRMT1 Activator Combination to Restore Ph | 0.848 | neurodegeneration | What is the therapeutic window between i |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 2 hypotheses Top: 0.611
neurodegeneration | 2026-04-03 | 42 hypotheses Top: 0.910
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.703
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.756
neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| MAPK pathway inhibition by QTJD through butyrate mechanism | exploratory | Mycoplasma pneumoniae pneumoni | 0.900 | 0.00 | Mouse macrophages | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.90 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-06
closed · Rounds: 4 · Score: 0.89 · 2026-04-06
closed · Rounds: 4 · Score: 0.95 · 2026-04-06
closed · Rounds: 4 · Score: 0.94 · 2026-04-04
closed · Rounds: 4 · Score: 0.95 · 2026-04-03
Hypotheses and analyses mentioning P38 in their description or question text
No additional research found